Old-school growth stocks look like they really make sense now for investors looking ahead to 2017. These have been hit harder than some of their peers and may have bigger upside potential for investors…
One thing smart investors should keep in mind is things that are said and promised during a red-hot election need to be taken with a gigantic grain of salt.
After a dramatic conclusion to the presidential race, insider buying was dramatically larger than we have seen in months, and it could continue the rest of the year.
It was decidedly bullish to see so much insider buying come in after the election results. It was also bullish to see so little selling.
With the Republicans now set to control both Congress and the White House, many on Wall Street feel that there could be far less scrutiny on drug pricing.
These companies are doing outstanding on their own, and the potential for additional revenue from a hot new Facebook project is just more fuel for the proverbial fire.
A new research report from Stifel makes the case that pure-play defense stocks may be a solid choice for investors to consider now.
The analysts at Merrill Lynch have made a big move by adding a top property and casualty company to the firm's well-respected US 1 list of stocks to Buy.
While there are no guarantees, these four stocks look solid and offer investors a chance to buy the companies below their acquisition price.
RBC thinks investors can buy these biotech stocks now, because the timing in their view is irrelevant, and they see the stocks de-risked and having mergers and acquisitions potential.
We get the sense the various Wall Street strategists we cover think that the best way for investors to be situated in 2017 is in very large cap stocks that pay solid dividends.
In a recent research note, the analysts at Jefferies make a big move by removing a top medical devices company from the firm's well-respected Franchise Picks list of stocks.
While these out-of-favor stocks may still remain volatile, buying these top companies at deep discounts may end up being one of the best trades for the rest of 2016 and 2017.
With earnings for the third quarter wrapping up, executives and 10% owners that are insiders are once again free to trade shares, and volume is starting to pick up again.
While there was some insider selling, it was dwarfed by the overall volume of insider buying, which is a positive for investors, to be sure.
These four top companies are posting great numbers and look solid for 2017. They make sense for those seeking alpha in their portfolios.
One solid strategy for uncertain times is to buy big blue chip stocks that pay dividends that will do well regardless of what happens.
The need for speed is going nowhere but up, and these top network companies will continue to be at the forefront.
Typically when investors are nervous over political elections or global macro uneasiness, they turn to the precious metal as a safe haven.
The recent headlines and the huge Trump following have helped closed the gap on Clinton, and if Trump is declared the winner, we could see a large market drop next week.
